- LivaNova to Present at the Goldman Sachs Healthcare Conference
- LivaNova Reports First-Quarter 2024 Results
- LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
- LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
- LivaNova to Announce First-Quarter 2024 Results
- LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
- LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
- LivaNova to Present at the Barclays Global Healthcare Conference
More ▼
Key statistics
As of last trade LivaNova PLC (LIA:MUN) traded at 55.50, -5.93% below its 52-week high of 59.00, set on May 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 55.50 |
---|---|
High | 55.50 |
Low | 55.50 |
Bid | 54.00 |
Offer | 55.50 |
Previous close | 56.00 |
Average volume | 2.67 |
---|---|
Shares outstanding | 54.15m |
Free float | 53.68m |
P/E (TTM) | -- |
Market cap | 3.22bn USD |
EPS (TTM) | -0.5911 USD |
Data delayed at least 15 minutes, as of May 24 2024 07:15 BST.
More ▼